Managing HHRH: Balancing Bone and Kidney Health

Treating Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) requires a specialized approach that differs significantly from other forms of rickets. Because HHRH affects both the bones and the kidneys, the goal of treatment is twofold: to heal the skeleton by restoring phosphate levels and to protect the kidneys by reducing calcium in the urine ^[1][2].

The Standard Approach: Oral Phosphate

The usual first-line treatment for HHRH is oral phosphate supplementation ^[1][3].

In HHRH, the kidneys “leak” phosphate, which leads to soft bones and triggers the body to produce too much of its own active vitamin D. Providing oral phosphate helps in two ways:

1. Bone Healing: It gives the bones the mineral they need to harden, which can improve leg bowing, bone pain, and growth ^[4][2].
2. Kidney Protection: By raising blood phosphate levels, the body reduces its overproduction of active vitamin D. This, in turn, reduces the amount of calcium absorbed by the gut and eventually lowers the amount of calcium dumped into the urine ^[1][5].

While oral phosphate can normalize blood phosphate and urine calcium levels over time for many, treatment response varies. Some individuals may continue to experience kidney or bone issues even on treatment, which is why close specialist follow-up is critical ^[5][6].

A Critical Distinction: Active vs. Nutritional Vitamin D

It is vital for patients and caregivers to understand the difference between forms of vitamin D in HHRH management ^[1][2].

Active Vitamin D Analogs (Calcitriol, Alfacalcidol):

• These prescription medications are standard treatments for other types of rickets (like XLH), but they are generally contraindicated in HHRH.
• Because the body in HHRH is already overproducing its own active vitamin D, adding more via medication can cause a dangerous spike in urine calcium, significantly increasing the risk of painful kidney stones and nephrocalcinosis ^[1][7].

Nutritional Vitamin D (Cholecalciferol, Ergocalciferol):

• This is the standard over-the-counter vitamin D that the general population takes for basic health. Patients with HHRH can still develop standard nutritional vitamin D deficiencies. If a doctor detects a nutritional deficiency via a 25-hydroxyvitamin D blood test, they may prescribe standard nutritional vitamin D.
• Never start, stop, or change any vitamin D supplement without explicit direction from your treating specialist.

Adjunctive Therapies for Kidney Health

If a patient continues to have high levels of calcium in their urine despite oral phosphate, specialists may add adjunctive medications:

• Thiazide Diuretics: Medications like chlorthalidone or hydrochlorothiazide help the kidneys reabsorb calcium back into the blood instead of letting it pass into the urine ^[3][8]. These require careful medical monitoring of volume status, blood pressure, sodium, and potassium levels.
• Potassium Citrate: This may be used for specific stone-risk findings (like hypocitraturia). It makes the urine less acidic and increases “citrate” levels, which helps prevent calcium from clumping together to form stones ^[9][10].

These prescription decisions are typically managed by a nephrologist (kidney specialist) ^[2].

Practical Medication Safety and Monitoring

Phosphate supplements must often be taken several times a day and can sometimes cause gastrointestinal side effects like stomach upset or diarrhea ^[4][3].

• Missed Doses & Illness: If a dose is missed, or if the patient is experiencing vomiting or diarrhea from an illness, do not “double up” on phosphate doses. Call your care team for guidance on how to manage medications during intercurrent illness.
• Diet and Hydration: Maintain excellent daily fluid intake to naturally protect the kidneys. Do not self-restrict dietary sodium or calcium unless directed by a renal dietitian or nephrologist, as restricting calcium can worsen bone health.
• Specialist Follow-Up: Your medical team will use blood tests, urine tests, and periodic renal ultrasounds to ensure the treatment is working safely and the kidneys remain protected ^[11][12].